Sanara MedTech (SMTI)
NASDAQ:SMTI
Total Valuation
Sanara MedTech has a market cap or net worth of $158.04M. The enterprise value is $189.65M.
Market Cap$158.04M
Enterprise Value$189.65M
Share Statistics
Sanara MedTech has 9,167,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,167,040
Owned by Insiders2.80%
Owned by Institutions1.63%
Financial Efficiency
Sanara MedTech’s return on equity (ROE) is -6.33 and return on invested capital (ROIC) is 16.73%.
Return on Equity (ROE)-6.33
Return on Assets (ROA)-0.51
Return on Invested Capital (ROIC)16.73%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee731.33K
Profits Per Employee-196.14K
Employee Count141
Asset Turnover1.41
Inventory Turnover2.58
Valuation Ratios
The current PE Ratio of Sanara MedTech is ―. Sanara MedTech’s PEG ratio is -0.02.
PE Ratio―
PS Ratio1.95
PB Ratio33.96
Price to Fair Value33.96
Price to FCF93.17
Price to Operating Cash Flow21.90
PEG Ratio-0.02
Income Statement
In the last 12 months, Sanara MedTech had revenue of 103.12M and earned -37.56M in profits. Earnings per share was -4.36.
Revenue103.12M
Gross Profit92.94M
Operating Income9.15M
Pretax Income-393.12K
Net Income-37.56M
EBITDA11.81M
Earnings Per Share (EPS)-4.36
Cash Flow
In the last 12 months, operating cash flow was 6.79M and capital expenditures -4.63M, giving a free cash flow of 2.16M billion.
Operating Cash Flow6.79M
Free Cash Flow2.16M
Free Cash Flow per Share0.24
Dividends & Yields
Sanara MedTech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.23
52-Week Price Change-37.42%
50-Day Moving Average19.65
200-Day Moving Average25.63
Relative Strength Index (RSI)39.59
Average Volume (3m)61.65K
Important Dates
Sanara MedTech upcoming earnings date is May 18, 2026, Before Open (Confirmed).
Last Earnings DateMar 24, 2026
Next Earnings DateMay 18, 2026
Ex-Dividend Date―
Financial Position
Sanara MedTech as a current ratio of 1.80, with Debt / Equity ratio of 812.73%
Current Ratio1.80
Quick Ratio1.59
Debt to Market Cap0.23
Net Debt to EBITDA2.68
Interest Coverage Ratio1.35
Taxes
In the past 12 months, Sanara MedTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sanara MedTech EV to EBITDA ratio is 19.73, with an EV/FCF ratio of 107.80.
EV to Sales2.26
EV to EBITDA19.73
EV to Free Cash Flow107.80
EV to Operating Cash Flow34.33
Balance Sheet
Sanara MedTech has $16.58M in cash and marketable securities with $48.19M in debt, giving a net cash position of -$31.61M billion.
Cash & Marketable Securities$16.58M
Total Debt$48.19M
Net Cash-$31.61M
Net Cash Per Share-$3.45
Tangible Book Value Per Share-$1.89
Margins
Gross margin is 90.13%, with operating margin of 8.87%, and net profit margin of -36.43%.
Gross Margin90.13%
Operating Margin8.87%
Pretax Margin-0.38%
Net Profit Margin-36.43%
EBITDA Margin11.45%
EBIT Margin8.87%
Analyst Forecast
The average price target for Sanara MedTech is $36.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$36.00
Price Target Upside21.95% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast30.55%
EPS Growth Forecast-340.19%